These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 28328856)

  • 1. The influence of different growth hormone addition protocols to poor ovarian responders on clinical outcomes in controlled ovary stimulation cycles: A systematic review and meta-analysis.
    Li XL; Wang L; Lv F; Huang XM; Wang LP; Pan Y; Zhang XM
    Medicine (Baltimore); 2017 Mar; 96(12):e6443. PubMed ID: 28328856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study.
    Choe SA; Kim MJ; Lee HJ; Kim J; Chang EM; Kim JW; Park HM; Lyu SW; Lee WS; Yoon TK; Kim YS
    Arch Gynecol Obstet; 2018 Mar; 297(3):791-796. PubMed ID: 29264647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Higher probability of live-birth in high, but not normal, responders after first frozen-embryo transfer in a freeze-only cycle strategy compared to fresh-embryo transfer: a meta-analysis.
    Bosdou JK; Venetis CA; Tarlatzis BC; Grimbizis GF; Kolibianakis EM
    Hum Reprod; 2019 Mar; 34(3):491-505. PubMed ID: 30689865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis.
    Cozzolino M; Cecchino GN; Troiano G; Romanelli C
    Fertil Steril; 2020 Jul; 114(1):97-109. PubMed ID: 32553470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials.
    Yang P; Wu R; Zhang H
    Reprod Biol Endocrinol; 2020 Jul; 18(1):76. PubMed ID: 32727608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone co-treatment in IVF/ICSI cycles in poor responders.
    Ob'edkova K; Kogan I; Krikheli I; Dzhemlikhanova L; Muller V; Mekina I; Lesik E; Komarova E; Mazilina M; Niauri D; Gzgzyan A; Aylamazyan E
    Gynecol Endocrinol; 2017; 33(sup1):15-17. PubMed ID: 29264990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Administration of growth hormone improves endometrial function in women undergoing in vitro fertilization: a systematic review and meta-analysis.
    Shang Y; Wu M; He R; Ye Y; Sun X
    Hum Reprod Update; 2022 Nov; 28(6):838-857. PubMed ID: 35641113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of growth hormone plus gonadotropins on controlled ovarian stimulation in infertile women of advanced age, poor responders, and previous in vitro fertilization failure patients.
    Ho YK; Lee TH; Lee CI; Cheng EH; Huang CC; Huang LS; Lee MS
    Taiwan J Obstet Gynecol; 2017 Dec; 56(6):806-810. PubMed ID: 29241924
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis.
    Zhang Y; Zhang C; Shu J; Guo J; Chang HM; Leung PCK; Sheng JZ; Huang H
    Hum Reprod Update; 2020 Feb; 26(2):247-263. PubMed ID: 32045470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; Aboulfoutouh I; Khattab SM; van Wely M
    Cochrane Database Syst Rev; 2011 Jan; (1):CD008046. PubMed ID: 21249699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gonadotropin-releasing hormone agonist versus HCG for oocyte triggering in antagonist assisted reproductive technology cycles.
    Youssef MA; Van der Veen F; Al-Inany HG; Griesinger G; Mochtar MH; van Wely M
    Cochrane Database Syst Rev; 2010 Nov; (11):CD008046. PubMed ID: 21069701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone supplementation during ovarian stimulation improves oocyte and embryo outcomes in IVF/PGT-A cycles of women who are not poor responders.
    Skillern A; Leonard W; Pike J; Mak W
    J Assist Reprod Genet; 2021 May; 38(5):1055-1060. PubMed ID: 33534048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does growth hormone supplementation improve oocyte competence and IVF outcomes in patients with poor embryonic development? A randomized controlled trial.
    Li J; Chen Q; Wang J; Huang G; Ye H
    BMC Pregnancy Childbirth; 2020 May; 20(1):310. PubMed ID: 32434490
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcomes of
    Chen Y; Tao L; Lin Y; Li X; Ma C
    Gynecol Endocrinol; 2020 Nov; 36(11):955-958. PubMed ID: 32172647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual trigger with combination of gonadotropin-releasing hormone agonist and human chorionic gonadotropin significantly improves the live-birth rate for normal responders in GnRH-antagonist cycles.
    Lin MH; Wu FS; Lee RK; Li SH; Lin SY; Hwu YM
    Fertil Steril; 2013 Nov; 100(5):1296-302. PubMed ID: 23993928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ovarian stimulation for freeze-all IVF cycles: a systematic review.
    Mizrachi Y; Horowitz E; Farhi J; Raziel A; Weissman A
    Hum Reprod Update; 2020 Jan; 26(1):118-135. PubMed ID: 31867625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone co-treatment on controlled ovarian stimulation in normal ovarian response women can improve embryo quality.
    Liu X; Bai H; Xie J; Shi J
    Gynecol Endocrinol; 2019 Sep; 35(9):787-791. PubMed ID: 30907187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
    Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evidence of growth hormone for infertile women with diminished ovarian reserve undergoing IVF: a systematic review and meta-analysis.
    Lin G; Zhong X; Li S; Xu L
    Front Endocrinol (Lausanne); 2023; 14():1215755. PubMed ID: 38027219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical diminished ovarian reserve after endometrioma cystectomy versus idiopathic DOR: comparison of in vitro fertilization outcome.
    Roustan A; Perrin J; Debals-Gonthier M; Paulmyer-Lacroix O; Agostini A; Courbiere B
    Hum Reprod; 2015 Apr; 30(4):840-7. PubMed ID: 25740883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.